Halozyme Therapeutics, Inc. HALO
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $1.4B | +38% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Operating income | $469.0M | -15% | FY ending Dec 31, 2025 |
| Net income | $316.9M | -29% | FY ending Dec 31, 2025 |
| Earnings per share | $2.56 | -25% | FY ending Dec 31, 2025 |
| Research & development | $81.5M | +3% | FY ending Dec 31, 2025 |
| Cash from operations | $651.6M | +36% | FY ending Dec 31, 2025 |
| Capital spending | $7.0M | -35% | FY ending Dec 31, 2025 |
| Share buybacks | $342.4M | +37% | FY ending Dec 31, 2025 |
| Cash | $133.8M | +16% | FY ending Dec 31, 2025 |
| Long-term debt | $2.1B | +42% | FY ending Dec 31, 2025 |
| Shareholders' equity | $48.8M | -87% | FY ending Dec 31, 2025 |
| Shares outstanding | 118M | -4% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 42 sales ($48.4M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan4 fills | 20,000 | $109.40 avg | $2.2M | Oct 8, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan4 fills | 20,000 | $111.55 avg | $2.2M | Oct 7, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan4 fills | 20,000 | $109.58 avg | $2.2M | Oct 6, 2026 |
| Matthew L. PosardDirector | Soldpre-set plan4 fills | 5,230 | $108.54 avg | $568K | Oct 1, 2026 |
| Matthew L. PosardDirector | Soldpre-set plan4 fills | 18,996 | $107.74 avg | $2.0M | Sep 16, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 20,000 | $107.24 avg | $2.1M | Sep 11, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 20,000 | $107.17 avg | $2.1M | Sep 10, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan3 fills | 20,000 | $107.43 avg | $2.1M | Sep 9, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan3 fills | 20,000 | $107.00 avg | $2.1M | Aug 19, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan3 fills | 20,000 | $104.18 avg | $2.1M | Aug 18, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan5 fills | 20,000 | $102.60 avg | $2.1M | Aug 17, 2026 |
| Bernadette ConnaughtonDirector | Soldpre-set plan | 1,626 | $102.80 | $167K | Aug 10, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 1,923 | $79.77 avg | $153K | Jul 8, 2026 |
| Bernadette ConnaughtonDirector | Soldpre-set plan2 fills | 1,625 | $76.71 avg | $125K | Jul 1, 2026 |
| Mahesh KrishnanDirector | Soldpre-set plan | 7,304 | $75.00 | $548K | Jun 29, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan4 fills | 10,000 | $69.07 avg | $691K | Jun 3, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 20,000 | $66.39 avg | $1.3M | Jun 2, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan3 fills | 20,000 | $67.58 avg | $1.4M | Jun 1, 2026 |
| Bernadette ConnaughtonDirector | Soldpre-set plan | 1,625 | $66.21 | $108K | Jun 1, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan4 fills | 10,000 | $69.19 avg | $692K | May 13, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan5 fills | 20,000 | $71.75 avg | $1.4M | May 12, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan3 fills | 20,000 | $65.35 avg | $1.3M | May 11, 2026 |
| Bernadette ConnaughtonDirector | Soldpre-set plan | 1,625 | $63.48 | $103K | May 1, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 10,000 | $63.50 avg | $635K | Apr 6, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 20,000 | $64.24 avg | $1.3M | Apr 2, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 20,000 | $65.38 avg | $1.3M | Apr 1, 2026 |
| Cortney CaudillSVP, CHIEF OPERATING OFFICER | Sold | 8,857 | $67.64 | $599K | Mar 10, 2026 |
| Cortney CaudillSVP, CHIEF OPERATING OFFICER | Sold2 fills | 20,000 | $67.80 avg | $1.4M | Mar 9, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 10,000 | $70.21 avg | $702K | Mar 4, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 20,000 | $69.01 avg | $1.4M | Mar 3, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan3 fills | 20,000 | $69.69 avg | $1.4M | Mar 2, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 10,000 | $78.64 avg | $786K | Feb 5, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 20,000 | $77.24 avg | $1.5M | Feb 4, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan3 fills | 20,000 | $76.12 avg | $1.5M | Feb 3, 2026 |
| Bernadette ConnaughtonDirector | Soldpre-set plan | 2,000 | $70.25 | $140K | Jan 5, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan4 fills | 16,569 | $68.92 avg | $1.1M | Dec 1, 2025 |
| Bernadette ConnaughtonDirector | Soldpre-set plan | 829 | $71.60 | $59K | Dec 1, 2025 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan3 fills | 20,000 | $70.55 avg | $1.4M | Nov 12, 2025 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan3 fills | 20,000 | $69.13 avg | $1.4M | Nov 11, 2025 |
| Helen TorleyPRESIDENT AND CEO, Director | Soldpre-set plan2 fills | 20,000 | $68.72 avg | $1.4M | Nov 10, 2025 |
Other insider moves (69): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $18.41 | $368K | Oct 8, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $18.41 | $368K | Oct 7, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $18.41 | $368K | Oct 6, 2026 |
| James M DalyDirector | Award | 1,169 | – | – | Oct 1, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $18.41 | $368K | Sep 11, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $18.41 | $368K | Sep 10, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $18.41 | $368K | Sep 9, 2026 |
| Dannielle AppelhansDirector | Award | 1,161 | – | – | Sep 1, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $18.41 | $368K | Aug 19, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $18.41 | $368K | Aug 18, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $18.41 | $368K | Aug 17, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 1,923 | $12.07 | $23K | Jul 8, 2026 |
| David A RamsayEVP, PRESIDENT, DRUG DELIVERY | Tax withholding | 5,408 | $78.27 | $423K | Jun 30, 2026 |
| David A RamsayEVP, PRESIDENT, DRUG DELIVERY | Option exercise | 10,000 | – | – | Jun 30, 2026 |
| Mahesh KrishnanDirector | Option exercisepre-set plan | 7,304 | $38.46 | $281K | Jun 29, 2026 |
| Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Tax withholding | 2,715 | $69.50 | $189K | Jun 12, 2026 |
| Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Option exercise | 5,034 | – | – | Jun 12, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 10,000 | $12.07 | $121K | Jun 3, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $12.07 | $241K | Jun 2, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $12.07 | $241K | Jun 1, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 10,000 | $12.07 | $121K | May 13, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $12.07 | $241K | May 12, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $12.07 | $241K | May 11, 2026 |
| Matthew L. PosardDirector | Award | 3,796 | – | – | May 5, 2026 |
| Mahesh KrishnanDirector | Award | 3,796 | – | – | May 5, 2026 |
| James Paul LangDirector | Award | 3,796 | – | – | May 5, 2026 |
| Jeffrey William HendersonDirector | Award | 3,796 | – | – | May 5, 2026 |
| Barbara Gayle DuncanDirector | Award | 3,796 | – | – | May 5, 2026 |
| Bernadette ConnaughtonDirector | Award | 6,796 | – | – | May 5, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 10,000 | $12.07 | $121K | Apr 6, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $12.07 | $241K | Apr 2, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $12.07 | $241K | Apr 1, 2026 |
| Cortney CaudillSVP, CHIEF OPERATING OFFICER | Option exercise | 1,546 | $33.51 | $52K | Mar 10, 2026 |
| Cortney CaudillSVP, CHIEF OPERATING OFFICER | Option exercise | 20,000 | $33.51 | $670K | Mar 9, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 10,000 | $12.07 | $121K | Mar 4, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $12.07 | $241K | Mar 3, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $12.07 | $241K | Mar 2, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Tax withholding | 12,104 | $70.64 | $855K | Feb 23, 2026 |
| Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Tax withholding | 3,782 | $70.64 | $267K | Feb 23, 2026 |
| Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | Tax withholding | 3,608 | $70.64 | $255K | Feb 23, 2026 |
| Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Option exercise | 7,011 | – | – | Feb 23, 2026 |
| Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | Option exercise | 6,688 | – | – | Feb 23, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercise | 22,436 | – | – | Feb 23, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Tax withholding | 9,040 | $70.98 | $642K | Feb 20, 2026 |
| Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Tax withholding | 2,876 | $70.98 | $204K | Feb 20, 2026 |
| Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | Tax withholding | 2,876 | $70.98 | $204K | Feb 20, 2026 |
| Cortney CaudillSVP, CHIEF OPERATING OFFICER | Tax withholding | 1,037 | $70.98 | $74K | Feb 20, 2026 |
| Cortney CaudillSVP, CHIEF OPERATING OFFICER | Option exercise | 2,666 | – | – | Feb 20, 2026 |
| Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Option exercise | 5,332 | – | – | Feb 20, 2026 |
| Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | Option exercise | 5,332 | – | – | Feb 20, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercise | 16,757 | – | – | Feb 20, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Tax withholding3 fills | 48,043 | $79.44 avg | $3.8M | Feb 16, 2026 |
| Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | Tax withholding3 fills | 12,894 | $79.44 avg | $1.0M | Feb 16, 2026 |
| Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Tax withholding2 fills | 9,068 | $79.44 avg | $720K | Feb 16, 2026 |
| Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Option exercise2 fills | 16,812 | – | – | Feb 16, 2026 |
| Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | Option exercise3 fills | 23,773 | – | – | Feb 16, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercise3 fills | 89,055 | – | – | Feb 16, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 10,000 | $12.07 | $121K | Feb 5, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $12.07 | $241K | Feb 4, 2026 |
| Helen TorleyPRESIDENT AND CEO, Director | Option exercisepre-set plan | 20,000 | $12.07 | $241K | Feb 3, 2026 |
Trades by members of Congress
1 member reported 1 buy and 2 sales since Mar 24, 2025. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Sep 29, 2026 | Oct 12, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Mar 9, 2026 | Apr 7, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Mar 24, 2025 | Apr 7, 2025 | Self |
Latest SEC filings
- News filing: Executive or board change 8-K · Sep 30, 2026
- News filing: Signed a major agreement, Took on new debt, Sold unregistered shares 8-K · Sep 22, 2026
- News filing: Other news 8-K · Sep 18, 2026
- Insider plans to sell 144 · Sep 16, 2026
- News filing: Other news 8-K · Sep 16, 2026
- News filing: Executive or board change 8-K · Aug 18, 2026
- Insider plans to sell 144 · Aug 17, 2026
- Insider plans to sell 144 · Aug 11, 2026
- Insider plans to sell 144 · Aug 10, 2026
- Quarterly report 10-Q · Aug 6, 2026
- News filing: Quarterly results 8-K · Aug 6, 2026
- News filing: Executive or board change 8-K · Jul 2, 2026
- Insider plans to sell 144 · Jun 29, 2026
- Insider plans to sell 144 · May 15, 2026
- Insider plans to sell 144 · May 11, 2026
- Quarterly report 10-Q · May 11, 2026
- News filing: Quarterly results 8-K · May 11, 2026
- News filing: Shareholder vote results 8-K · May 7, 2026
- Insider plans to sell 144 · May 1, 2026
- News filing: Executive or board change 8-K · Apr 30, 2026
- News filing: Bylaws or fiscal year changed 8-K · Apr 24, 2026
- Shareholder meeting proxy DEF 14A · Mar 23, 2026
- News filing: Executive or board change 8-K · Mar 12, 2026
- Insider plans to sell 144 · Mar 10, 2026
- Insider plans to sell 144 · Mar 9, 2026
About Halozyme Therapeutics, Inc.
Business description
- Industry
- Biological Products, (No Diagnostic Substances)
- Sector
- Life Sciences
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- Nasdaq
- Filer size
- Large accelerated filer
- Formerly
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- SEC company number (CIK)
- 1159036
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.